Security key
00973Y108
AKERO THERAPEUTICS, INC. - Common Stock (AKRO)
CUSIP: 00973Y108
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 82,872,659
- Total 13F shares
- 73,002,070
- Share change
- +1,038,031
- Total reported value
- $2,094,264,742
- Put/Call ratio
- 258%
- Price per share
- $28.69
- Number of holders
- 167
- Value change
- +$38,454,830
- Number of buys
- 78
- Number of sells
- 72
Report period
Q3 2024
Institutions
167
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 00973Y108
Recent filing periods:
Top shareholders of AKRO - AKERO THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of AKERO THERAPEUTICS, INC. - Common Stock (AKRO) as of Q3 2024
As of 30 Sep 2024,
AKERO THERAPEUTICS, INC. - Common Stock (AKRO) was held by
167 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,002,070 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, BlackRock, Inc., GENERAL ATLANTIC, L.P., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, and ALLIANCEBERNSTEIN L.P..
This page lists
167
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
152
Q3 2024 holders
167
Holder diff
15
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.